Skip to main content
See every side of every news story
Published • loading... • Updated

CareDx Stock Rockets 22% After Blowout Quarter and Big Guidance Hike, Extending a Nearly 500% One-Year Run

CareDx shares surged after the transplant diagnostics company beat third-quarter expectations, reported stronger testing growth and raised its 2026 revenue and adjusted EBITDA forecasts.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

IBTimes Australia broke the news in New York, United States on Monday, November 2, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal